Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age
Yuka Uesugi,
Daisuke Ikeda,
Ami Fukumoto,
Rikako Tabata,
Daisuke Miura,
Kentaro Narita,
Masami Takeuchi,
Kosei Matsue
Affiliations
Yuka Uesugi
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
Daisuke Ikeda
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
Ami Fukumoto
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
Rikako Tabata
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
Daisuke Miura
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
Kentaro Narita
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
Masami Takeuchi
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
Kosei Matsue
Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba
